May 19, 2020
Small Cell Lung Cancer (SCLC) Market Insights, Epidemiology and Forecast to 2030
May 12, 2020
Non-Small Cell Lung Cancer (NSCLC) Market Forecasts to 2030: A Comprehensive Insight
May 06, 2020
Targovax Announces That Abstract on Interim Phase I Clinical Data From the Phase I/II Peritoneal Trial is Accepted at ASCO
Apr 27, 2020
I-SPY2 TRIAL Demonstrates Significant Improvement in pCR with Durvalumab and Olaparib with Paclitaxel, (Compared to Chemotherapy Alone) in Women with Stage II/III High-Risk, HER2-Negative Breast Cancer, in HR+ and TNBC Subsets
Apr 20, 2020
HTA in Major Pharma Industries, 2020 - Includes Profiles of Daratumumab (Darzalex), Tildrakizumab (Ilumya), Durvalumab (Imfinzi), Abemaciclib (Verzenio), and Ocrelizumab (Ocrevus)
Mar 16, 2020
2020 Market Spotlight: Small-Cell Lung Cancer (SCLC)
Feb 27, 2020
$200B+ Cancer Immunotherapy Market Opportunity Insights, 2026 - Cancer Vaccines, Monoclonal Antibodies, Trials of T-Cell Therapies, Pipeline Overview, Competitive Landscape, and More
Feb 20, 2020
Small Cell Lung Cancer Market Size is Expected to Increase at a CAGR of 13.2% for the Study Period (2017-2030) in the 7MM | Some Market Key Players - AstraZeneca, PharmaMar, EpicentRx, United Therapeutics, Ipsen, G1 Therapeutics, Otsuka Holdings, Takeda
Nov 12, 2019
Inovio Pharmaceuticals Reports 2019 Third Quarter Financial Results
Nov 11, 2019
Global Urothelial Carcinoma Market Insights, Epidemiology and Market Forecasts Report 2019-2028
Nov 06, 2019
Patients Turn to Advanced Technology in Order to Combat Cancer
Sep 09, 2019
IASLC World Conference on Lung Cancer--Summary of the Presidential Symposium Research
Sep 08, 2019
IASLC World Conference on Lung Cancer--Press Briefing Summary from Sunday, September 8th
May 15, 2019
Data Presentations at ASCO 2019 Highlight Lilly's Targeted Approach to Developing Treatments for Patients Living with Cancer
Apr 08, 2019
Inovio Achieves Third Cancer Indication Milestone for MEDI0457 Phase 2 Development
Mar 31, 2019
Apexigen Announces New Clinical Data On APX005M In Combination Therapy For Pancreatic Cancer At The AACR Annual Meeting 2019
Mar 12, 2019
Inovio Pharmaceuticals Reports 2018 Fourth Quarter and Year-End Financial Results
Jan 07, 2019
Sosei Heptares to Receive US$15 Million Milestone Payment From AstraZeneca With First Partnered Program Moving Towards Phase 2
Nov 09, 2018
Mirati Presents Data From Ongoing Phase 2 Clinical Trial Of Mocetinostat In Combination With Durvalumab At The SITC 33rd Annual Meeting
Nov 05, 2018
Mirati To Present New Data In Ongoing Phase 2 Clinical Trials At The SITC 33rd Annual Meeting